Monoamine oxidase B (MAO-B) serves as a critical target in the management of neurodegenerative diseases (NDDs) such as Alzheimer’s and Parkinson’s due to its role in regulating oxidative stress and dopamine metabolism. The gene discussed is MAOB; the disease is Parkinsonism.